The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Brentuximub vedotin (Brand name: Adcetris)
- Manufactured by
Seattle Genetics, Inc
FDA-approved indication: The treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen. Also, for adult patients with primary cutaneous anaplastic large cell lymphoma.
National Library of Medicine Drug Information PortalMedline Plus Health Information